Works about SIBUTRAMINE

Results: 339

Sibutramin Etkinliğinin Psikopatoloji ve Yeme Patolojisi İle İliğkisi.

Published in:

Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S275

By:

Akalın, Aysen;
Yazıcı, Fadime;
Erol, Atila

Publication type:

Article

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.

Published in:: Public Health Nutrition, 2007, v. 10, n. 0, p. 1200, doi. 10.1017/S1368980007000717
Publication type:: Article

UPDATE: Meridia Is Withdrawn from the Market.

Published in:: Eating Disorders Review, 2010, v. 21, n. 1, p. 2
Publication type:: Article

Sibutramine for Binge Eating Disorder.

Published in:

Eating Disorders Review, 2008, v. 19, n. 1, p. 12

By:

J. Y.

Publication type:

Article

QUESTIONS & ANSWERS.

Published in:: Eating Disorders Review, 2005, v. 16, n. 3, p. 8
Publication type:: Article

DETERMINATION OF SIBUTRAMINE ADULTERATED IN HERBAL SLIMMING PRODUCTS USING TLC DENSITOMETRIC METHOD.

Published in:

Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2016, v. 27, n. 1, p. 15, doi. 10.14499/indonesianjpharm27iss1pp15

By:

Hayun;
Maggadani, Baitha P.;
Amalina, Nurul

Publication type:

Article

Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2011, v. 36, n. 5, p. 592, doi. 10.1111/j.1365-2710.2010.01217.x

By:

Derosa, G.;
Maffioli, P.;
Ferrari, I.;
Palumbo, I.;
Randazzo, S.;
D'Angelo, A.;
Cicero, A. F. G.

Publication type:

Article

Effect of the G-protein β3 subunit 825T allele on the change of body adiposity in obese female.

Published in:

Diabetes, Obesity & Metabolism, 2013, v. 15, n. 3, p. 284, doi. 10.1111/dom.12023

By:

Hwang, I. C.;
Kim, K. K.;
Ahn, H. Y.;
Suh, H. S.;
Oh, S. W.

Publication type:

Article

Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine.

Published in:

Diabetes, Obesity & Metabolism, 2012, v. 14, n. 11, p. 1050, doi. 10.1111/j.1463-1326.2012.01629.x

By:

Klein, T.;
Niessen, H. G.;
Ittrich, C.;
Mayoux, E.;
Mueller, H.-P.;
Cheetham, S.;
Stiller, D.;
Kassubek, J.;
Mark, M.

Publication type:

Article

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.

Published in:

Diabetes, Obesity & Metabolism, 2012, v. 14, n. 6, p. 523, doi. 10.1111/j.1463-1326.2011.01554.x

By:

Caterson, I. D.;
Finer, N.;
Coutinho, W.;
Van Gaal, L. F.;
Maggioni, A. P.;
Torp-Pedersen, C.;
Sharma, A. M.;
Legler, U. F.;
Shepherd, G. M.;
Rode, R. A.;
Perdok, R. J.;
Renz, C. L.;
James, W. P. T.

Publication type:

Article

Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta-analysis.

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, n. 5, p. 385, doi. 10.1111/j.1463-1326.2010.01346.x

By:

Osei-Assibey, G.;
Adi, Y.;
Kyrou, I.;
Kumar, S.;
Matyka, K.

Publication type:

Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 3, p. 262, doi. 10.1111/j.1463-1326.2010.01202.x

By:

Idris, Iskandar

Publication type:

Article

Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 1, p. 26, doi. 10.1111/j.1463-1326.2009.01090.x

By:

Van Gaal, L. F.;
Caterson, I. D.;
Coutinho, W.;
Finer, N.;
Maggioni, A. P.;
Sharma, A. M.;
Torp-Pedersen, C.;
Ge, H.;
Moran, S. A.;
Shepherd, G. M.;
James, W. P. T.

Publication type:

Article

Herbal Weight Loss Pill Overdose: Sibutramine Hidden in Pepper Pill.

Published in:

Case Reports in Emergency Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/213874

By:

Pamukcu Gunaydin, Gul;
Dogan, Nurettin Ozgur;
Levent, Sevcan;
Kurtoglu Celik, Gulhan

Publication type:

Article

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats.

Published in:

2006

By:

Fisas, Angels;
Codony, Xavier;
Romero, Gonzalo;
Dordal, Alberto;
Giraldo, Jesus;
Mercé, Ramon;
Holenz, Jörg;
Heal, David;
Buschmann, Helmut;
Pauwels, Petrus Johan;
Mercé, Ramon;
Holenz, Jörg;
Vrang, N;
Sørensen, R V

Publication type:

journal article

EFFECTS OF DIET ON THE REGIONAL HAEMODYNAMIC RESPONSES TO SIBUTRAMINE IN CONSCIOUS RATS.

Published in:: British Journal of Pharmacology, 2002, v. 137, p. 53
Publication type:: Article

REGIONAL HAEMODYNAMIC EFFECTS OF THE 5-HT AND NORADRENALINE RE-UPTAKE INHIBITOR, SIBUTRAMINE, IN CONSCIOUS RATS: EFFECTS OF α-OR β-ADRENOCEPTOR ANTAGONISM.

Published in:: British Journal of Pharmacology, 2002, v. 137, p. 52
Publication type:: Article

Safety Assessment of an Anti-Obesity Drug (Sibutramine).

Published in:

Drug Safety, 2012, v. 35, n. 8, p. 629, doi. 10.2165/11599220-000000000-00000

By:

Tyczynski, Jerzy E.;
Oleske, Denise M.;
Klingman, David;
Ferrufino, Cheryl P.;
Won Chan Lee

Publication type:

Article

Safety of drug therapies used for weight loss and treatment of obesity.

Published in:

2006

By:

Ioannides-Demos, Lisa L.;
Proietto, Joseph;
Tonkin, Andrew M.;
McNeil, John J.

Publication type:

journal article

Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.

Published in:

2006

By:

De Santis, Marco;
Straface, Gianluca;
Cavaliere, Anna F.;
Carducci, Brigida;
Caruso, Alessandro

Publication type:

journal article

A Benefit-Risk Assessment of Sibutramine in the Management of Obesity.

Published in:

Drug Safety, 2003, v. 26, n. 14, p. 1027, doi. 10.2165/00002018-200326140-00004

By:

Nisoli, Enzo;
Carruba, Michele O.

Publication type:

Article

Efficacy of low dose sibutramine in obese type-2 diabetes mellitus (T2DM) Indian patients.

Published in:

Middle East Journal of Family Medicine, 2012, v. 10, n. 3, p. 29

By:

Gupta, Ashwani K.;
Badyal, Dinesh K.;
Matreja, Prithpal S.;
Khosla, Prem P.;
John, Mary

Publication type:

Article

From the Editor.

Published in:

Middle East Journal of Family Medicine, 2012, v. 10, n. 3, p. 2

By:

Abyad, A.

Publication type:

Article

An investigation on alteration of intracellular pH by sibutramine via confocal imaging.

Published in:

2018

By:

Tekeş, Feyza Alyu;
Olğar, Yusuf;
Turan, Belma;
Öztürk, Yusuf

Publication type:

Abstract

Behavior Therapy and Sibutramine for the Treatment of Adolescent Obesity: A Randomized Controlled Trial.

Published in:

JAMA: Journal of the American Medical Association, 2003, v. 289, n. 14, p. 1805, doi. 10.1001/jama.289.14.1805

By:

Berkowitz, Robert I.;
Wadden, Thomas A.;
Tershakovec, Andrew M.;
Cronquist, Joanna L.

Publication type:

Article

LETTERS.

Published in:

2002

By:

Donnelly, William J.;
Paris, Mary R.;
Yanes-Hoffman, Nancy;
Henderson, C. Brooks;
Charon, Rita;
Langer, M.;
Riccardi, F.;
Piovella, F.;
Klersy, C.;
Opal, Steven M.;
Knaub, Sigurd;
Behring, Aventis;
Ransom, Thomas;
Wirth, Alfred;
Hersh, Adam;
Von Reyn, C. Fordham;
Herzmann, Christian;
Mazurek, Gerald H.;
Furmanski, Martin

Publication type:

Letter

Long-term Weight Loss With Sibutramine.

Published in:

JAMA: Journal of the American Medical Association, 2001, v. 286, n. 11, p. 1331, doi. 10.1001/jama.286.11.1331

By:

Wirth, Alfred;
Krause, Jutta

Publication type:

Article

ChemDIS: a chemical-disease inference system based on chemical-protein interactions.

Published in:

Journal of Cheminformatics, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13321-015-0077-3

By:

Chun-Wei Tung

Publication type:

Article

Multidisciplinary Intervention With Sibutramine: Assessing Successful Weight Loss Predictors in Military Adolescent Dependents.

Published in:

Military Medicine, 2012, v. 177, n. 3, p. 308, doi. 10.7205/MILMED-D-11-00334

By:

Cabrera, Jorge L.;
Wilks, Edward G.;
Symons, Jenna E.;
Blankson, Kwabena L.;
Cole, Renee E.

Publication type:

Article

Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States.

Published in:

JGIM: Journal of General Internal Medicine, 2012, v. 27, n. 1, p. 51, doi. 10.1007/s11606-011-1828-0

By:

Cohen, Pieter A.;
Benner, Carly;
McCormick, Danny

Publication type:

Article

Track 5b: Management - pharmacotherapy.

Published in:: 2004
Publication type:: Abstract

Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2004, v. 28, n. 4, p. 600, doi. 10.1038/sj.ijo.0802591

By:

Kaukua, J.K.;
Pekkarinen, T.A.;
Rissanen, A.M.

Publication type:

Article

Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2004, v. 28, n. 3, p. 378, doi. 10.1038/sj.ijo.0802574

By:

Ersoz, H. O.;
Ukinc, K;
Baykan, M;
Erem, C;
Durmus, I;
Hacihasanoglu, A;
Telatar, M

Publication type:

Article

Short-term effects of sibutramine (Reductil<sup><sup>TM</sup></sup>) on appetite and eating behaviour and the long-term therapeutic outcome.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2003, v. 27, n. 6, p. 693, doi. 10.1038/sj.ijo.0802298

By:

Barkeling, B;
Elfhag, K;
Rooth, P;
Rossner, S

Publication type:

Article

The metabolic challenge of obesity: impact of weight management on improvement of metabolic risk factors. A one-day symposium held in April 2002.

Published in:

2002

By:

James, W P T;
Sharma, A

Publication type:

Editorial

Sibutramine: its mode of action and efficacy.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2002, v. 26, p. S29, doi. 10.1038/sj.ijo.0802216

By:

Finer, N

Publication type:

Article

Metabolic benefits associated with sibutramine therapy.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2002, v. 26, p. S34, doi. 10.1038/sj.ijo.0802217

By:

Krejs, G J

Publication type:

Article

Sibutramine and its cardiovascular profile.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2002, v. 26, p. S38, doi. 10.1038/sj.ijo.0802218

By:

Narkiewicz, K

Publication type:

Article

Mechanism of thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2002, v. 26, n. 9, p. 1245, doi. 10.1038/sj.ijo.0802062

By:

Liu, Y.-L.;
Heal, D.J.;
Stock, M.J.

Publication type:

Article

Sibutramine-dependent brown fat activation in rats: an immunohistochemical study.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2002, v. 26, n. 3, p. 354, doi. 10.1038/sj.ijo.0801926

By:

Giordano, A.;
Centemeri, C.;
Zingaretti, M.C.;
Cinti, S.

Publication type:

Article

The role of sibutramine in weight loss management; Symposium held on 5-6 April 2001, Rome, Italy.

Published in:

2001

By:

James, W P T

Publication type:

Editorial

When, for whom and how to use sibutramine.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S2, doi. 10.1038/sj.ijo.0801930

By:

Astrup, A;
Toubro, S

Publication type:

Article

How does sibutramine work?

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S8, doi. 10.1038/sj.ijo.0801931

By:

Lean, M E J

Publication type:

Article

Sibutramine in clinical practice.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S12, doi. 10.1038/sj.ijo.0801932

By:

Finer, N

Publication type:

Article

Sibutramine in overweight/obese hypertensive patients.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S20, doi. 10.1038/sj.ijo.0801934

By:

Sharma, A M

Publication type:

Article

The importance of obesity in diabetes and its treatment with sibutramine.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S24, doi. 10.1038/sj.ijo.0801935

By:

Van Gaal, L F;
Peiffer, F W

Publication type:

Article

The role of sibutramine in weight management-towards a blueprint for a sibutramine weight management system.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, p. S34, doi. 10.1038/sj.ijo.0801937

By:

James, W P T;
Finer, N

Publication type:

Article

Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet–exercise intervention.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, n. 8, p. 1144

By:

Bérubé-Parent, S;
Prud'homme, D;
St-Pierre, S;
Doucet, E;
Tremblay, A

Publication type:

Article

Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, n. 5, p. 741

By:

Fanghänel, G;
Cortinas, L;
Sánchez-Reyes, L;
Berber, A

Publication type:

Article

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, n. 4, p. 496

By:

Hansen, D L;
Astrup, A;
Toubro, S;
Finer, N;
Kopelman, P;
Hilsted, J;
Rössner, S;
Saris, W H M;
Van Gaal, L F;
James, W P T;
Goulder, M

Publication type:

Article